Gregory Neaville
Internal Medicine · Batesville, ARNPI 1336140839
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,031 and has fallen 88.9% since, to $114 in 2023.
Across 171 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$463
- Novartis$411
- Novo Nordisk$202
- Pfizer$193
- Merck$155
- Sanofi-aventis U.S. LLC$142
- plus $872 from 23 others
What the payments were for
- Food & beverage$2,42399%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $463 |
| Novartis | 25 | $411 |
| Novo Nordisk | 14 | $202 |
| Pfizer | 19 | $193 |
| Merck | 11 | $155 |
| Sanofi-aventis U.S. LLC | 12 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $101 |
| Daiichi Sankyo Inc. | 5 | $83 |
| Astellas Pharma US Inc | 5 | $78 |
| Dexcom, Inc. | 4 | $71 |
| Biogen | 4 | $56 |
| Abbott | 3 | $55 |
| Lundbeck LLC | 3 | $50 |
| Nestle Healthcare Nutrition Inc. | 3 | $50 |
| Mylan Specialty L.p. | 3 | $42 |
| Boehringer Ingelheim | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| AstraZeneca | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| AbbVie | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Bayer | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
| GSK | 1 | $11 |
How this compares
$2,438 in reported general payments places this provider in the 80th percentile of 614 internal medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Citalopram HbrCitalopram Hydrobromide | 11 | $674 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $521 |
| Pantoprazole Sodium | 31 | $286 |
| Omeprazole | 26 | $274 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $266 |
| Gabapentin | 19 | $237 |
| Levothyroxine Sodium | 33 | $234 |
| Atorvastatin Calcium | 32 | $228 |
| Potassium Chloride | 17 | $191 |
| Famotidine | 14 | $143 |
| Escitalopram Oxalate | 12 | $143 |
| Amlodipine Besylate | 22 | $121 |
| Lisinopril | 19 | $116 |
| Trazodone Hcl | 11 | $103 |
| Furosemide | 22 | $74 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Batesville
- Atif KhanBatesville$14K
- Doreen KamogaBatesville$10K
- David PyleJonesboro$93K
- Aaron StrobelLittle Rock$32K
- Stuart BensonRogers$24K
- Purnima SarkarEarle$21K
- John NorwoodJonesboro$21K
- Ahmed AliConway$18K
- Jeremy DavisLittle Rock$17K
- Tyree SealsFort Smith$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.